Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Ibrutinib in Combination with Venetoclax Decreases Mitochondrial Bioenergetics through the Impaired BTK, AKT and AMPK/SIRT/PGC-1α Signaling Pathway in CLL

Subir Roy Chowdhury, MD PhD, Amandeep Singh, MSc, Edwin Nguyen, Aaron Marshall, PhD, James B. Johnston, MD, Spencer Bruce Gibson, PhD, Versha Banerji, MD

Blood (2019) 134 (Supplement_1): 1282.

https://doi.org/10.1182/blood-2019-127562

Published: 2019

Journal Articles

A Descriptive Analysis of Obinutuzumab Usage in a Single Canadian Centre

Nicole Bourrier, BSc, Ivan Landego, MD, Mandy Squires, CCRP, HIT, Oliver Bucher, Zeb Aurangzeb, Erin Streu, MSN, RN, CON (C), Theresa Whiteside, RN, BN, CON (C), Irena Hibbert, RN, BN, CON (C), Marc Geirnaert, BSc Pharm, David Dawe, MD FRCPC, Spencer Bruce Gibson, PhD, James B. Johnston, MD FRCP, Versha Banerji, MD

Blood (2018) 132 (Supplement 1): 5838.

https://doi.org/10.1182/blood-2018-99-113422

Published: 2018

Journal Articles

A Distributed International Patient Data Registry for Hairy Cell Leukemia

Leslie A. Andritsos, MD, Michael R. Grever, MD, Mirela Anghelina, MD, Claire E Dearden, MD FRCP, FRCPath, Monica Else, MA, MSc, James S. Blachly, MD, Omkar Lele, MS, MBA, Farhad Ravandi, MD, Clive S Zent, MD, James B. Johnston, MD FRCP, Versha Banerji, MD FRCP, Francesco Forconi, MD DM, PhD FRCPath, Anthony D. Ho, MD, Thorsten Zenz, Sascha Dietrich, Judit Demeter, MD PhD, Jacqueline C. Barrientos, MD, Jan A. Burger, MD PhD, Timothy G. Call, MD, Nicholas Chiorazzi, MD, Daniel J. DeAngelo, MD PhD, Julio Delgado, MD, Andrei Fagarasanu, MD PhD, Brunangelo Falini, Alessandro Gozzetti, MD, Jeffrey Jones, MD MPH, Gunnar Juliusson, MD, Eric H. Kraut, MD, Robert J. Kreitman, MD, Loree Larratt, MD, Francesco Lauria, MD, Gerard Lozanski, MD, Emili Montserrat, MD, Sameer A. Parikh, MD, Jae H. Park, MD, Aaron Polliack, MD, Graeme R. Quest, MD MSc, Kanti R. Rai, MD, Tadeusz Robak, MD PhD, Alan Saven, MD, Tamar Tadmor, MD, Martin S. Tallman, MD, Constantine S. Tam, MBBS, Enrico Tiacci, MD, Xavier Troussard, MD PhD, Omar Abdel-Wahab, MD, Pier Luigi Zinzani, MD, PhD, Christopher Heckler, BS, MBA, Philip R.O. Payne, PhD

Blood (2016) 128 (22): 5986.

https://doi.org/10.1182/blood.V128.22.5986.5986

Published: 2016

Journal Articles

Revelance of Gammaglobulin Levels at Diagnosis and during Disease Course in Chronic Lymphocytic Leukemia

Erin Streu, RN MN CON(C), Jayce Bi, Mandy DeSousa, Versha Banerji, MD FRCP, Dhali H.S. Dhaliwal, MD FRCP, Sara Beiggi, PhD, James B. Johnston, MD FRCP

Blood (2016) 128 (22): 5561.

https://doi.org/10.1182/blood.V128.22.5561.5561

Published: 2016

Journal Articles

Incidence and Implications of Skin Cancers in Cancercare Manitoba Chronic Lymphocytic Leukemia (CLL) Clinic Patients

Sara Beiggi, PhD, Mohammad Pannu, Versha Banerji, MD FRCP, Dhali H.S. Dhaliwal, MD FRCP, Spencer B. Gibson, PhD, Marni Wiseman, MD FRCP, James B. Johnston, MD FRCP

Blood (2016) 128 (22): 4359.

https://doi.org/10.1182/blood.V128.22.4359.4359

Published: 2016

Journal Articles

High Cumulative Illness Rating Scale (CIRS) Score in CLL Correlates with Short CLL Telomere Length and Decreased Survival

Lin Yang, Sara Beiggi, PhD, Yunli Zhang, Sara Kost, Robert Schmidt, BSc, Gangimeg Ishdorj, Dhali H.S. Dhaliwal, MD FRCP, Versha Banerji, MD FRCP, Sabine Mai, PhD, Spencer B. Gibson, PhD, James B. Johnston, MD FRCP

Blood (2016) 128 (22): 4362.

https://doi.org/10.1182/blood.V128.22.4362.4362

Published: 2016

Journal Articles

An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)

Christine I Chen, MD, Harminder Paul, Susi Snitzler, RN, Lisa W Le, MSc, Ellen Nong Wei, Anthea Lau, James B Johnston, MD, Spencer B. Gibson, PhD, Michelle L. Queau, B.Sc, Suzanne Trudel, MD

Blood (2015) 126 (23): 4163.

https://doi.org/10.1182/blood.V126.23.4163.4163

Published: 2015

Journal Articles

A Phase 2 Study of Ofatumumab in Combination with a Pan-AKT Inhibitor (Afuresertib) in Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)

Christine I Chen, MD, Susi Snitzler, RN, Olga Levina, RN, Tong (Trina) Wang, RN, Lisa W Le, MSc, Harminder Paul, Ellen Nong Wei, Anthea Lau, Michelle Queau, James B Johnston, MD, Suzanne Trudel, MD, Deborah A Smith

Blood (2015) 126 (23): 1742.

https://doi.org/10.1182/blood.V126.23.1742.1742

Published: 2015

Journal Articles

Lysosome Membrane Permeabilization Causes Cell Death in Primary Chronic Lymphocytic Leukemia Cells

Rebecca Dielschneider, BSc, Hannah Eisenstat, James B. Johnston, MD, Spencer B Gibson, PhD

Blood (2014) 124 (21): 930.

https://doi.org/10.1182/blood.V124.21.930.930

Published: 2014

Journal Articles

Clinical Impact of Telomere Shortening in Normal and Leukemia Cells in Chronic Lymphocytic Leukemia

Lin Yang, MD PhD, Sara Beiggi, PhD, Yunli Zhang, Robert Schmidt, Spencer B Gibson, PhD, James B. Johnston, MD

Blood (2014) 124 (21): 5641.

https://doi.org/10.1182/blood.V124.21.5641.5641

Published: 2014

Journal Articles

Final Report Of a Phase II Clinical Trial Of Lenalidomide Monotherapy For T-Cell Lymphoma

Ethan Toumishey, B. Sc, Angeli Prasad, CCRP, Gregory S. Dueck, MD, MSc, BSc, FRCPC, Neil Chua, MD, FRCPC, Daygen Finch, MD, Douglas A. Stewart, MD, FRCPC, Darrell J. White, MD, Richard H. van der Jagt, MD, FRCPC, James B Johnston, MD, Andrew R Belch, MD, Tony Reiman, MD

Blood (2013) 122 (21): 4376.

https://doi.org/10.1182/blood.V122.21.4376.4376

Published: 2013

Journal Articles

An Open-Label Phase 2 Study Of Ofatumumab In Combination With a Novel AKT Inhibitor (Afuresertib) In Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL)

Christine I. Chen, MD, Susi Snitzler, RN, Trina Wang, RN, Harminder Paul, Lisa W Le, Ellen Nong Wei, MSc, Anthea Lau, Deborah A Smith, PharmD, Michelle Brown, James B Johnston, MD, Suzanne Trudel, MD, MSC, FRCPC

Blood (2013) 122 (21): 4175.

https://doi.org/10.1182/blood.V122.21.4175.4175

Published: 2013

Journal Articles

Effectiveness and Cost of Rituximab for CLL in the Province of Manitoba Prior to Its Approval As Part of First Line Treatment

Pamela Skrabek, FRCPC, Rajat Kumar, FRCPC, James B Johnston, MD, Joseph Baptiste, MD, Bernie Lozar, Scott Streilein, Venetia Bourrier, FCSHP, Sri Navaratnam, FRCPC

Blood (2012) 120 (21): 4701.

https://doi.org/10.1182/blood.V120.21.4701.4701

Published: 2012

Journal Articles

The Valproic Acid-Fludarabine Combination Induces a Synergistic Response in Chronic Lymphocytic Leukemia Via a Mechanism Involving the Lysosomal Protease Cathepsin B.

Ju-Yoon Yoon, David Szwajcer, MD, FRCPC, Ganchimeg Ishdorj, PhD, Pat Benjaminson, RN, CON(C), James B Johnston, MD, Spencer B Gibson, PhD

Blood (2012) 120 (21): 2892.

https://doi.org/10.1182/blood.V120.21.2892.2892

Published: 2012

Journal Articles

An Open-Label Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in the Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL).

Christine Chen, MD, Harminder Paul, Luisa Del Rizzo, Lisa W Le, MSc, Ellen Nong Wei, Anthea Lau, James B Johnston, MD, Spencer B Gibson, PhD, Michelle Brown, Suzanne Trudel, MD

Blood (2012) 120 (21): 2895.

https://doi.org/10.1182/blood.V120.21.2895.2895

Published: 2012

Journal Articles

Functional and Familial Risk of B Lineage Malignancies in Patients Carrying Single Nucleotide Polymorphisms (SNPs) in the Hyaluronan Synthase 1 Gene (HAS1),

Linda M. Pilarski, PhD, Hemalatha Kuppusamy, Jitra Kriangkum, PhD, Amanda Warkentin, Sunita Ghosh, PhD, Spencer B Gibson, PhD, Hlif Steingrimsdottir, MD, Vilhelmina Haraldsdottir, MD, James B Johnston, MD, FRCPC, Helga M Ogmundsdottir, MD, PhD, Andrew R Belch, MD

Blood (2011) 118 (21): 3930.

https://doi.org/10.1182/blood.V118.21.3930.3930

Published: 2011

Journal Articles

Effect of Valproic Acid (VPA) on Fludarabine Activity In Chronic Lymphocytic Leukemia (CLL) Patients

Ju-Yoon Yoon, MSc, HonBSc, David Szwajcer, MD, FRCP(C), Ganchimeg Ishdorj, PhD, Pat Benjaminson, RN, CON(C), Spencer B Gibson, PhD, James B Johnston, MD, FRCPC

Blood (2010) 116 (21): 4626.

https://doi.org/10.1182/blood.V116.21.4626.4626

Published: 2010

Journal Articles

Younger Patients with CLL/SLL Are Less Frequent and Have Favorable Survival in a Canadian Population Based Study: The Manitoba Cohort.

Versha Banerji, MD, FRCPC, Alain Demers, PhD, James B. Johnston, MD FRCPC, Marshall W. Pitz, MD FRCPC, Zoanne Nugent, PhD, Carmen Morales, MD, Salah Mahmud, MD MS, Donna Hewitt, RN, Spencer B. Gibson, PhD, Matthew D. Seftel, MD FRCPC

Blood (2006) 108 (11): 3335.

https://doi.org/10.1182/blood.V108.11.3335.3335

Published: 2006

Journal Articles

The Induction of Apoptosis by Histone Deacetylase Inhibition in Chronic Lymphocytic Leukemia (CLL) Cells Is Mediated through the TNF-Related Apoptosis-Inducing Ligand (TRAIL) Pathway.

David Szwajcer, MD, Spencer B. Gibson, PhD, James B. Johnston, MD

Blood (2005) 106 (11): 2982.

https://doi.org/10.1182/blood.V106.11.2982.2982

Published: 2005

Journal Articles

The Role of Proteasome Inhibitors and the Trail Apoptotic Pathway in the Treatment of Chronic Lymphocytic Leukemia.

Kristin E. McCrea, BSc, Albert Kabore, Ph.D, James B. Johnston, MD, Spencer B. Gibson, Ph.D

Blood (2005) 106 (11): 5011.

https://doi.org/10.1182/blood.V106.11.5011.5011

Published: 2005

NARROW

Ibrutinib in Combination with Venetoclax Decreases Mitochondrial Bioenergetics through the Impaired BTK, AKT and AMPK/SIRT/PGC-1α Signaling Pathway in CLL

A Descriptive Analysis of Obinutuzumab Usage in a Single Canadian Centre

A Distributed International Patient Data Registry for Hairy Cell Leukemia

Revelance of Gammaglobulin Levels at Diagnosis and during Disease Course in Chronic Lymphocytic Leukemia

Incidence and Implications of Skin Cancers in Cancercare Manitoba Chronic Lymphocytic Leukemia (CLL) Clinic Patients

High Cumulative Illness Rating Scale (CIRS) Score in CLL Correlates with Short CLL Telomere Length and Decreased Survival

An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)

A Phase 2 Study of Ofatumumab in Combination with a Pan-AKT Inhibitor (Afuresertib) in Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)

Lysosome Membrane Permeabilization Causes Cell Death in Primary Chronic Lymphocytic Leukemia Cells

Clinical Impact of Telomere Shortening in Normal and Leukemia Cells in Chronic Lymphocytic Leukemia

Final Report Of a Phase II Clinical Trial Of Lenalidomide Monotherapy For T-Cell Lymphoma

An Open-Label Phase 2 Study Of Ofatumumab In Combination With a Novel AKT Inhibitor (Afuresertib) In Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL)

Effectiveness and Cost of Rituximab for CLL in the Province of Manitoba Prior to Its Approval As Part of First Line Treatment

The Valproic Acid-Fludarabine Combination Induces a Synergistic Response in Chronic Lymphocytic Leukemia Via a Mechanism Involving the Lysosomal Protease Cathepsin B.

An Open-Label Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in the Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL).

Functional and Familial Risk of B Lineage Malignancies in Patients Carrying Single Nucleotide Polymorphisms (SNPs) in the Hyaluronan Synthase 1 Gene (HAS1),

Effect of Valproic Acid (VPA) on Fludarabine Activity In Chronic Lymphocytic Leukemia (CLL) Patients

Younger Patients with CLL/SLL Are Less Frequent and Have Favorable Survival in a Canadian Population Based Study: The Manitoba Cohort.

The Induction of Apoptosis by Histone Deacetylase Inhibition in Chronic Lymphocytic Leukemia (CLL) Cells Is Mediated through the TNF-Related Apoptosis-Inducing Ligand (TRAIL) Pathway.

The Role of Proteasome Inhibitors and the Trail Apoptotic Pathway in the Treatment of Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only